The company has raised nearly £14.5m of funding via a seed (2004) and series-A (2007 / 2010) from Blue chip investors including the Novartis Venture Fund, HealthCap, Truffle Capital, the London Technology and Esperante Ventures. This funding also included £0.5m grant funding from the London Development Agency.

Key investors include:

1        Novartis Venture Fund

2        HealthCap

3        Truffle Capital

4        SME Wholesale Finance

5        Esperante Ventures

Key Stakeholders

1        London Development Agency